Capitolis Advisors LLC Biogen Inc. Transaction History

Capitolis Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $2.12 Million - $2.68 Million	-10,958 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $3.1 Million - $4.04 Million	10,958 New	10,958 $2.96 Million
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $2.41 Million - $3.85 Million	-9,291 Closed	0 $0
Q4 2020 May 07, 2021	BUY	$236.26 - $355.63 $2.2 Million - $3.3 Million	9,291 New	9,291 $2.28 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Capitolis Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Capitolis Advisors LLC with notifications on news.